✦ LIBER ✦

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

✍ Scribed by Wenhao Guo; Yu Zhang; Ting Chen; Yongsheng Wang; Jianxin Xue; Yonggang Zhang; Wenjing Xiao; Xianming Mo; You Lu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor M2-pyruvate kinase in the follow-u

✍ Joachim Schneider; Kathleen Neu; Hans-Georg Velcovsky; Harald Morr; Erich Eigenb 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Evaluation of the costs and efficacy of

✍ Ozturk, C; Kokturk, N; Sener, M; Levent, E 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Cisplatin versus cisplatin combined with

✍ Deborah W. Knapp; Nita W. Glickman; William R. Widmer; Dennis B. DeNicola; Larry 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 89 KB

A phase II study of irinotecan combined

✍ Kudoh, S.; Kurihara, N.; Fukuoka, M.; Fujiwara, Y.; Furuse, K.; Ikegami, H.; Ari 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Individual dose and scheduling determine

✍ Johannes Meiler, Melanie Guyot, Sandra Hoffarth, Emmanuelle Wesarg, Yvonne Höhn, 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 450 KB

Trimetrexate combined with cisplatin or

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 155 KB